These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
545 related items for PubMed ID: 23489534
1. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E, Yıldız M, Oğuz E, Aykan AÇ, Ertürk E, Karavelioğlu Y, Gökdeniz T, Kaya H, Gürsoy OM, Çakal B, Karakoyun S, Duran N, Özdemir N. JACC Cardiovasc Imaging; 2013 Feb; 6(2):206-16. PubMed ID: 23489534 [Abstract] [Full Text] [Related]
2. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, Aykan AÇ, Çakal B, Bayram Z, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T, Duran NE, Yıldız M, Esen AM. Am Heart J; 2015 Aug; 170(2):409-18. PubMed ID: 26299240 [Abstract] [Full Text] [Related]
3. Obstructive Thrombosis of Left-Sided Mechanical Heart Valves: Clinical Profile and Thrombolytic Therapy. Chandrakasu A, Jayachandran A, Gopinath Nayar P, Meyyappan C, Narayan G, Basha Abdul Bari A, Johnson Samuel P. J Heart Valve Dis; 2017 May; 26(3):344-348. PubMed ID: 29092121 [Abstract] [Full Text] [Related]
4. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. Özkan M, Kalçık M, Gürsoy MO, Öcal L, Griffini S, Karakoyun S, Yesin M, Gündüz S, Astarcıoğlu MA, Bayam E, Cerşit S, Aykan AÇ, Cugno M. J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322 [Abstract] [Full Text] [Related]
5. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, Oğuz AE, Gündüz S, Astarcioglu MA, Aykan AÇ, Bayram Z, Biteker M, Kaynak E, Kahveci G, Duran NE, Yıldız M. Circulation; 2013 Jul 30; 128(5):532-40. PubMed ID: 23812180 [Abstract] [Full Text] [Related]
6. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. Ozkan M, Kaymaz C, Kirma C, Sönmez K, Ozdemir N, Balkanay M, Yakut C, Deligönül U. J Am Coll Cardiol; 2000 Jun 30; 35(7):1881-9. PubMed ID: 10841239 [Abstract] [Full Text] [Related]
7. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. Lengyel M, Vegh G, Vandor L. J Heart Valve Dis; 1999 Mar 30; 8(2):167-73. PubMed ID: 10224577 [Abstract] [Full Text] [Related]
8. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis. Kathirvel D, Justin Paul G, Prathap Kumar G, Palanisamy G, Gnanavelu G, Ravishankar G, Swaminathan N, Venkatesan S. Indian Heart J; 2018 Mar 30; 70(4):506-510. PubMed ID: 30170645 [Abstract] [Full Text] [Related]
9. Prosthetic valve thrombosis: when and how should we lyse? Vemulapalli S, Patel MR. JACC Cardiovasc Imaging; 2013 Feb 30; 6(2):217-9. PubMed ID: 23489535 [No Abstract] [Full Text] [Related]
10. Prolonged Infusions of Low-Dose Thrombolytics in Elderly Patients With Prosthetic Heart Valve Thrombosis. Gündüz S, Özkan M, Yesin M, Kalçık M, Gürsoy MO, Karakoyun S, Astarcıoğlu MA, Aykan AÇ, Gökdeniz T, Biteker M, Duran NE, Yıldız M. Clin Appl Thromb Hemost; 2017 Apr 30; 23(3):241-247. PubMed ID: 26447199 [Abstract] [Full Text] [Related]
11. Thrombolytic Therapy for Right-Sided Mechanical Pulmonic and Tricuspid Valves: The Largest Survival Analysis to Date. Taherkhani M, Hashemi SR, Hekmat M, Safi M, Taherkhani A, Movahed MR. Tex Heart Inst J; 2015 Dec 30; 42(6):543-7. PubMed ID: 26664307 [Abstract] [Full Text] [Related]
13. Treatment of Prosthetic Valve Thrombosis with Bolus Dose Tenecteplase: An Experience from a Developing Country. Kumar Jha R, Bansal S, S Issar H, Chaudhary M, Sharma S. J Heart Valve Dis; 2017 May 30; 26(3):349-354. PubMed ID: 29092122 [Abstract] [Full Text] [Related]
14. Successful fibrinolytic treatment of prosthetic heart valve thrombosis using streptokinase. Sakr SA, Abdel-Shakour H, Ramadan MM. Acta Clin Belg; 2015 Jun 30; 70(3):159-66. PubMed ID: 25495280 [Abstract] [Full Text] [Related]
17. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events. Nagy A, Dénes M, Lengyel M. J Heart Valve Dis; 2009 May 30; 18(3):268-75. PubMed ID: 19557981 [Abstract] [Full Text] [Related]
18. Successful thrombolysis of a subacute prosthetic valve thrombosis with modified ultra-slow thrombolytic therapy. Altay H, Kocabaş U, Yıldırımtürk Ö, Özkalaycı F, Sarıtaş B, Pehlivanoğlu S. Echocardiography; 2018 Aug 30; 35(8):1243-1244. PubMed ID: 29943853 [Abstract] [Full Text] [Related]
19. A serial fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid prosthetic valve thrombosis with low-dose and ultra-slow infusion of tissue-type plasminogen activator. Kalçık M, Gürsoy OM, Astarcıoğlu MA, Özkan M. Turk Kardiyol Dern Ars; 2014 Jul 30; 42(5):478-81. PubMed ID: 25080958 [Abstract] [Full Text] [Related]
20. Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels. Farzaneh K, Mortazavi SH, Oraii A, Abbasi K, Salehi Omran A, Ahmadi Tafti SH, Bozorgi A, Kazemi Saeed A, Salarifar M, Sadeghian S. J Card Surg; 2020 Oct 30; 35(10):2522-2528. PubMed ID: 33043663 [Abstract] [Full Text] [Related] Page: [Next] [New Search]